NCT00000726View on ClinicalTrials.gov

Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 29, 1992

Conditions

Cytomegalovirus RetinitisHIV Infections

Interventions

DRUG

Foscarnet sodium

Trial Locations (5)

10021

Mem Sloan - Kettering Cancer Ctr, New York

90033

Los Angeles County - USC Med Ctr, Los Angeles

USC School of Medicine / Norris Cancer Hosp, Los Angeles

90095

UCLA CARE Ctr, Los Angeles

941102859

San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000726 - Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome | Biotech Hunter | Biotech Hunter